Brand Identity In Pharmaceutical Industry

1122 Words3 Pages

According to Moss (Schuiling and Moss, 2004), pharmaceutical companies have not worked proactively in identifying a brand identity for their products and in communicating this identity to consumers. They have not done market research to determine their brand identity and to verify if this is how consumers view them. Although brands exist in both the consumer goods and pharmaceutical industries, only the consumer goods industry is using brands as a competitive tool, managing its brands with care and investing resources in brand development. On the other hand, the pharmaceutical company has not understood and integrated the competitive advantage that brands could represent (Schuiling and Moss, 2004). The difference between the pharmaceutical and FMCG industries is also seen in the organisation of brand management. In the FMCG industry, branding is a strategic priority at every level of the organisation. Brands are created very early in the product development process and marketing people work in depth R&D at the beginning of the process. R&D for FMCG is relatively inexpensive and quick compared with R&D for pharmaceuticals. As a result, FMCG can focus on creating brands that will last decades, not 7-20 years. The marketing of these products is focused on maximizing the long-term brand growth rather than going after short-term return through a large sales force. In the pharmaceutical industry, it is often late in the development process when global marketing people become involved in the phase. Key decisions are taken at a much earlier phase of the product's development plan. Moreover, pharmaceutical marketing people are often more sales driven than marketing driven and therefore pay more attention to the elements during execution, r...

... middle of paper ...

... 2003). For decades, a pharmaceutical company's brand strategy was to discover a drug that was needed, introduce it to the doctor via a sales representative, and watch the prescriptions get filled. With several factors causing change in the pharmaceutical industry in the way in which medications are marketed and sold, it will be significantly important for these companies to brand their products. This will be important if more drugs are switched to over-the-counter (OTC), upon expiration by the FDA (Kapoor and Epstein, 2004) since many choices will be available on the shelf to choose from. As more drugs are switched to OTC in both pharmacies and supermarkets, healthcare is increasingly in the consumer's hands (Brand Strategy, 2004). The early years of the prescription lifecycle will be important for drug companies to establish brands that are ready to be switched.

Open Document